(19)
(11) EP 2 291 401 A2

(12)

(88) Date of publication A3:
18.02.2010

(43) Date of publication:
09.03.2011 Bulletin 2011/10

(21) Application number: 09746978.7

(22) Date of filing: 15.05.2009
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61P 37/00(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2009/003016
(87) International publication number:
WO 2009/139891 (19.11.2009 Gazette 2009/47)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 15.05.2008 US 53644 P

(71) Applicant: Acceleron Pharma, Inc.
Cambridge, MA 02139 (US)

(72) Inventors:
  • SEEHRA, Jasbir
    Lexington MA 02421 (US)
  • KNOPF, John
    Carlisle MA 01741 (US)
  • PEARSALL, Robert, S.
    Woburn MA 01801 (US)
  • GRINBERG, Asya
    Boston MA 02114 (US)
  • KUMAR, Ravindra
    Acton MA 01720 (US)

(74) Representative: Lock, Graham James et al
Fry Heath & Spence LLP The Gables Massetts Road
Horley Surrey RH6 7DQ
Horley Surrey RH6 7DQ (GB)

   


(54) ANTAGONISTS OF BMP9, BMP10, ALK1 AND OTHER ALK1 LIGANDS, AND USES THEREOF